
The DSM-5 Cross-Cutting Symptom Measure, also known as the DSM-XC, is a tool used to assess mental health symptoms across various psychiatric diagnoses. It is a self-report measure consisting of 23 items rated on a 5-point Likert scale across various domains, including depression, anger, anxiety, sleep problems, and repetitive thoughts/behaviors. The measure is designed to help clinicians gain a comprehensive understanding of a patient's mental health and identify areas that require further investigation. It can be used as an initial assessment tool and to track changes in symptom presentation over time. The DSM-XC is particularly useful for understanding how different combinations of symptoms at varying levels of severity may present across diverse diagnoses and their potential impact on patient outcomes. This measure is relevant for understanding when to use the DSM cross-cutting measure for sleep disturbance, as sleep problems are one of the domains assessed.
| Characteristics | Values |
|---|---|
| Number of questions | 23 |
| Number of domains | 13 |
| Frequency of use | Every 3-6 months |
| Scoring | 5-point scale (0=none, 4=severe) |
| Administration | Self-report |
| Purpose | Initial assessment, tracking changes, identifying areas requiring further investigation |
| Benefits | Easy to administer, score and interpret, freely available, good-to-excellent test-retest reliability, strong clinical utility |
Explore related products
What You'll Learn

Sleep disturbance as a psychiatric symptom
Sleep disturbances are a common occurrence in individuals with psychiatric disorders. Sleep problems can be both a symptom and a contributor to mental health issues. Sleep-wake disorders, for example, frequently co-occur with medical and mental health conditions such as depression, anxiety, and cognitive disorders. Insomnia, the most prevalent sleep disorder, is characterised by difficulty falling or staying asleep. About one-third of adults experience insomnia symptoms, and 4-22% meet the criteria for insomnia disorder.
The DSM-5 Cross-Cutting Symptom Measures (DSM-5 CC) provide a comprehensive overview of a patient's mental health symptoms, including sleep disturbances. The DSM-5 CC is designed to aid clinicians in understanding how different combinations of symptoms at varying severity levels may present across diverse diagnoses. It assesses 12-13 psychiatric symptom domains in adults, including sleep disturbance, depression, anger, anxiety, and substance use. The measure is easy to administer and interpret, and it can be used to guide treatment and prognosis.
Sleep disturbances can have a significant impact on an individual's daily functioning. They can lead to fatigue, decreased energy, irritability, and problems with focus and decision-making. Sleep problems can also exacerbate existing mental health conditions and contribute to chronic health issues such as heart disease, diabetes, and obesity. Therefore, it is crucial to address sleep disturbances as a critical aspect of psychiatric care.
The assessment and treatment of sleep disturbances involve a comprehensive evaluation, including a patient's history, a physical exam, a sleep diary, and clinical testing. A sleep diary records sleep habits such as bedtime, sleep onset, wake-up time, naps, exercise, and substance use. Initial assessments using the DSM-5 CC can help identify the presence and severity of sleep disturbances and other psychiatric symptoms, guiding further targeted interventions and treatments.
Treating sleep disturbances, such as insomnia, early on may be a preventive strategy for the onset of clinical disorders. Routine assessment of sleep problems in individuals with mental health disorders is recommended, as addressing sleep issues can help reduce the severity of other mental health difficulties. Sleep disturbances are a critical aspect of psychiatric care, and early intervention can potentially improve patient outcomes and overall mental health.
Sleep Studies: Hospital Insights for Better Sleep
You may want to see also
Explore related products

Level 1 and Level 2 CC Symptom measures
The DSM-5 CC Symptom measures are operationalized at two levels. Level 1 consists of a 23-item measure for adults and a 25-item measure for children/adolescents that assess the presence and severity of symptoms over the past two weeks. The items are rated on a 5-point scale, with higher scores indicating greater frequency or severity. Level 1 provides a brief survey of 13 domains for adults and 12 domains for children and adolescents.
Items on the Level 1 measure include depression, anger, mania, anxiety, somatic symptoms, sleep disturbance, psychosis, obsessive thoughts and behaviours, suicidal thoughts and behaviours, and substance use. If a patient scores a 2 or greater ("mild/several days") on any item, it triggers a more detailed assessment using the Level 2 measure.
Level 2 CC measures inquire about the presence and severity of symptoms within pure psychiatric domains during the past seven days. For example, the Altman Mania Scale is used for a more detailed assessment of mania if the respondent endorsed the Level 1 mania item with a score of 2 or greater. Level 2 measures provide a more in-depth assessment of certain domains.
The multi-domain nature of the Level 1 and 2 CC Symptom measures is a major strength. They allow clinicians and researchers to gain a better understanding of how different combinations of symptoms at varying levels of severity may present across diverse diagnoses and their potential impact on patient outcomes. The measures are easy to administer, score, and interpret, and they can be used to track changes in symptoms over time.
Unlocking Garmin Sleep Coach: A Guide to Better Sleep
You may want to see also
Explore related products

Administering the DSM-XC
The DSM-5-TR Level 1 Cross-Cutting Symptom Measure, also known as the DSM-XC, is a valuable tool in psychiatric assessment and treatment. It is a self-report measure that helps clinicians gain a broad overview of a patient's mental health symptoms, providing a window into their current concerns. The DSM-XC is typically administered as part of the initial assessment process, with follow-up measures used to gain a deeper understanding of the patient's needs and tailor treatments accordingly.
The DSM-XC consists of 23 items (for adults) or 25 items (for children/adolescents) rated on a 5-point scale, with higher scores indicating greater frequency or severity of symptoms. It covers various domains, including depression, anger, mania, anxiety, somatic symptoms, suicidal ideation, psychosis, sleep problems, memory, and repetitive thoughts/behaviors. The measure focuses on symptoms experienced in the past two weeks, making it a valuable up-to-date assessment tool.
The DSM-XC is just the first step in comprehensive psychiatric assessment. Domain-specific follow-up measures are essential to delve deeper into areas where patients show elevated scores. For example, if a patient rates 2 (mild) or higher on any item related to anxiety, the PROMIS Emotional Distress—Anxiety—Short Form is recommended as a follow-up measure. Similarly, the PROMIS-Sleep Disturbance-Short Form is suggested for scores of 2 or higher related to sleep disturbance.
The DSM-XC, along with other critical assessment tools, can be seamlessly integrated into psychiatry-focused EHR platforms, such as Osmind. This integration simplifies the administration, scoring, and interpretation of the measure, providing clear and measurable graphs of patient progress. By combining these tools, clinicians can access evidence-based data to shape the future of mental healthcare, making it more data-driven, personalized, and effective for each patient.
How InnaPeace Can Help You Sleep Better
You may want to see also
Explore related products

Scoring and interpreting the DSM-XC
The DSM-5 Cross-Cutting Symptom Measure (DSM-XC) is a valuable tool for clinicians and researchers, providing a broad overview of a patient's mental health symptoms. It aids in identifying additional areas of inquiry to guide treatment and prognosis. The DSM-XC is easy to administer, score, and interpret, especially in its electronic form. Even in pencil-and-paper form, it comes with detailed instructions for scoring and interpreting results.
The DSM-XC has two levels. Level 1 consists of a 23-item measure for adults or a 25-item measure for children/adolescents, assessing the presence and severity of symptoms over the past two weeks. The items are rated on a 5-point scale, with 0 representing "none/never" and 4 indicating "severe/almost daily". Higher scores denote a greater frequency or severity of symptoms. Suicide ideation, suicide attempts, and substance use in children/adolescents are scored with a yes/no response. Scores of 2 or higher, or a "yes" response, trigger a more detailed assessment using the Level 2 measures.
Level 2 provides an in-depth evaluation of specific domains. For sleep disturbance in adults, the Level 2 measure is the PROMIS Sleep Disturbance Short Form. This form is used when the patient scores 2 (mild) or higher on the initial DSM-XC assessment.
When interpreting the DSM-XC results, it is essential to consider the patient's unique context and look for changes in scores over time. Analyzing overall score trends can help gauge the general psychopathology burden. The DSM-XC provides a standardized way to communicate about comorbidity, remission, and recovery, allowing for more customized treatments.
Using Sleep Bands with Fitbit One: A Guide
You may want to see also
Explore related products

Benefits of the DSM-XC
The DSM-5 CC Symptom measures (DSM-XC) are designed to provide a broad overview of a patient's mental health symptoms, covering 12-13 psychiatric symptom domains that cut across diagnostic boundaries. This includes sleep disturbance, which is a common symptom of wider mental health issues.
The benefits of the DSM-XC include:
Standardised Communication
The DSM-XC provides a standardised way to communicate about comorbidity, remission, and recovery. This allows for more customised treatments to match different symptom profiles over time. The multi-domain nature of the Level 1 and 2 CC Symptom measures is a major strength, allowing clinicians and researchers to better understand how different combinations of symptoms present across diverse diagnoses and their potential impact on patient outcomes.
Easy Administration
The measures are easy to administer, score, and interpret, especially in their electronic form. Even in pencil-and-paper form, detailed instructions for scoring, summary sheets, and interpretation guides are provided. They can be easily incorporated into busy clinical settings and various practices, as demonstrated in DSM-5 field trials and pilot studies.
Identifying Additional Areas of Inquiry
The cross-cutting measures can aid in a comprehensive mental status assessment by drawing attention to symptoms that are important across diagnoses. They help identify additional areas of inquiry that may guide treatment and prognosis. Level 2 measures provide a more in-depth assessment of certain domains, allowing for a deeper understanding of patient needs and tailored treatments.
Initial and Ongoing Monitoring
The DSM-XC can be sent to patients before their first visit to establish a baseline and determine if Level 2 measures are warranted. For ongoing monitoring, the DSM-XC can be administered every 30 days for complex patients or every 60-90 days for lower acuity cases.
Analysing Trends
The DSM-XC allows clinicians to look for changes in scores over time and analyse overall score trends across measures to gauge general psychopathology burden. This can help identify patterns and the potential progression or improvement of symptoms, particularly relevant for sleep disturbances that may fluctuate over time.
David Yurman's Turquoise: The Sleeping Beauty Connection
You may want to see also
Frequently asked questions
The DSM-5 cross-cutting measure, also known as the DSM-XC, is a tool that helps clinicians assess mental health symptoms across various psychiatric diagnoses. It is a self-report measure consisting of 23 questions that cover 13 symptom domains, including sleep problems.
The DSM-5 cross-cutting measure provides a broad overview of a patient's mental health symptoms, allowing clinicians to gain a more comprehensive understanding of their mental health. It is easy to administer, score, and interpret, and is freely available for use.
The DSM-5 cross-cutting measure is typically used as part of the initial assessment process and then periodically during the course of treatment. The American Psychiatric Association (APA) recommends administering the measure every 3-6 months as a check-in to monitor changes in symptom presentation over time.
The DSM-5 cross-cutting measure can be used by sending the measure to patients before their first visit to establish a baseline. It asks about symptoms experienced in the past two weeks, providing an up-to-date window into current concerns. After reviewing the responses, clinicians can determine if Level 2 measures are warranted.
After administering the DSM-5 cross-cutting measure, clinicians should analyze the scores and look for any areas of concern. If a patient indicates concerns in a certain domain, the next steps are to send any more comprehensive relevant measures regarding that domain and inquire further during a visit.











































